134P Doxorubicin and olaparib (OLA) synergism in high-grade serous ovarian (HGOC) and triple-negative breast cancer (TNBC) cell lines with olaparib-resistance
Autor: | Fidalgo, J.A. Perez, Pretel, J.J. Martinez, Sanchez-Serrano, P., Heredia, V., Mendiola, M., Sanchez, A. Redondo, Burgues, O., Merlo, B. Pineda |
---|---|
Zdroj: | In ESMO Open October 2023 8(1) Supplement 5 |
Databáze: | ScienceDirect |
Externí odkaz: |